Get started
Author

Alla Sergeevna Salasyuk

Observed names: A S Salasyuk, A Salasyuk, A. S Salasyuk, A. S. Salasiuk, A. S. Salasyuk, A.S. Salasiuk, A.S. Salasyuk, A.S. Salasyuk Salasyuk, ALLA SALASYUK, AS Salasyuk, Alla S Salasyuk, Alla S. Salasyuk, Alla S. Salasyuk,, Alla Salasyuk, Саласюк Алла Сергеевна
ORCID: 0000-0002-6611-9165
Observed ORCID: 0000-0002-6611-9165
OpenAlex ID: A5005682824
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019 · Hertzel C Gerstein, Helen M Colhoun, et al. · The Lancet · 3,345
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
2019 · Hertzel C Gerstein, Helen M Colhoun, et al. · The Lancet · 665
2024 Clinical practice guidelines for Hypertension in adults
2024 · Zh. D. Kobalava, A. O. Konradi, et al. · Russian Journal of Cardiology · 274
PDF
Interdisciplinary Clinical Practice Guidelines "management of Obesity and Its Comorbidities"
2021 · I. I. Dedov, M. V. Shestakova, et al. · Obesity and metabolism · 163
PDF
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG
2021 · Subodh Verma, Deepak L. Bhatt, et al. · Circulation · 60
Randomized Trial of Perindopril, Enalapril, Losartan and Telmisartan in Overweight or Obese Patients with Hypertension
2013 · Sergey V. Nedogoda, Alla A. Ledyaeva, et al. · Clinical Drug Investigation · 58
Influence on the autonomic cardiovascular system regulation in the treatment of hypertension, arrhythmias and heart failure
2022 · E. V. Shlyakhto, A. O. Konradi, et al. · Russian Journal of Cardiology · 20
PDF
Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part I
2021 · Yu. M. Lopatin, S. V. Nedogoda, et al. · Russian Journal of Cardiology · 18
PDF
The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation
2018 · I E Chazova, T V Martynyuk, et al. · Terapevticheskii arkhiv · 17
National Clinical Recommendations for Obesity: Concept and Prospects
2017 · S. V. Nedogoda, I. N. Barykina, et al. · Journal of Volgograd State Medical University · 17
PDF
OPTIMAL ORGANOPROTECTION, CONTROL OF bLOOD PRESSURE AND METAbOLIC DISORDER WITH THE FIxED COMbINATION OF LISINOPRIL, AMLODIPINE AND ROSUVASTATIN IN SYSTEMIC HYPERTENSION
2018 · S. V. Nedogoda, E. V. Chumachek, et al. · Russian Journal of Cardiology · 13
PDF
Effectiveness of in insulin resistance correction and the adipokines level reduction in patients with arterial hypertension in comparison with other ARBs
2019 · S. V. Nedogoda, E. V. Chumachek, et al. · Russian Journal of Cardiology · 12
Effects of Melatonin on Blood Pressure, Endothelial Function and Vascular Stiffness in Patients With Metabolic Syndrome and Sleep Disorders
2017 · S. V. Nedogoda, V. O. Smirnova, et al. · Arterial’naya Gipertenziya (Arterial Hypertension) · 11
The concept of fixed-dose combination drugs in primary and secondary prevention of cardiovascular disease. Position paper of the Russian Society of Cardiology, the Russian Society for the Prevention of Noncommunicable Diseases, the Russian Scientific Medical Society of Internal Medicine, the Russian Association of Endocrinologists, the Association of Clinical Pharmacologists, the Eurasian Association of Internal Medicine, the Russian Association of Gerontologists and Geriatricians
2024 · G. P. Arutyunov, O. M. Drapkina, et al. · Russian Journal of Cardiology · 8
PDF
Identifying Early Vascular Ageing in Patients With Metabolic Syndrome: Unresolved Issues and a Proposed Novel VAmets Score
2021 · Sergey V. Nedogoda, Alla S. Salasyuk, et al. · Heart Lung and Circulation · 8
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT
2024 · Pascal M Burger, Deepak L Bhatt, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 7
Slow Release Melatonine in Metabolic Syndrome Sympthomatics Correction
2016 · V. O. Smirnova, I. N. Barykina, et al. · Russian Journal of Cardiology · 6
PDF
Optimization of blood pressure control, organ protection and metabolic disorders using a fixed-dose combination of lisinopril+amlodipine+rosuvastatin in hypertensive patients after COVID-19
2021 · S. V. Nedogoda, A. A. Ledyaeva, et al. · Russian Journal of Cardiology · 5
PDF
Early vascular aging in patients with metabolic syndrome: features of the course and diagnosis
2021 · S. V. Nedogoda, A. S. Salasyuk, et al. · South Russian Journal of Therapeutic Practice · 5
PDF
Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm
2021 · M. Yu. Frolov, A. S. Salasyuk, et al. · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · 5
PDF
The effect of various classes of glucose-lowering medications on the blood vessel elasticity in patients with type 2 diabetes
2020 · S. V. Nedogoda, I. N. Barykina, et al. · Russian Journal of Cardiology · 5
PDF
Pharmacoeconomic analysis of the use of dapagliflozin in patients with NYHA class II–IV chronic heart failure with reduced left ventricular ejection fraction ≤40% in the Russian Federation
2020 · Sergey V. Nedogoda, Sergey N. Tereshhenko, et al. · Consilium Medicum · 5
Improving blood pressure control, organoprotection and metabolic disorders correction in patients with hypertension switching from diuretic-based combinations to fixed combination lisinopril + amlodipine + rosuvastatin
2018 · S V Nedogoda, E V Chumachek, et al. · Systemic Hypertension · 5
Economic analysis of diabetes type 1 screening in children in the Russian Federation
2024 · S.V. Nedogoda, G.R. Galstyan, et al. · Medical Technologies Assessment and Choice · 4
Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part II
2022 · S. V. Nedogoda, Yu. M. Lopatin, et al. · Russian Journal of Cardiology · 4
PDF
Works count: 124
Citation count: 4,819
H-index: 12
I10-index: 13
Year
Topic
Type